The Current Ratio as of December 2025 (TTM) for SymBio Pharmaceuticals Limited (SYMQY) is 8.71

According to SymBio Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Current Ratio is 8.71. This represents a change of 16.21% compared to the average of 7.50 of the last 4 quarters.

SymBio Pharmaceuticals Limited (SYMQY) Historical Current Ratio (quarterly & annually)

How has SYMQY Current Ratio performed in the past?

The mean historical Current Ratio of SymBio Pharmaceuticals Limited over the last ten years is 5.77. The current 8.71 Current Ratio has changed 14.99% with respect to the historical average. Over the past ten years (40 quarters), SYMQY's Current Ratio was at its highest in in the September 2015 quarter at 33.19. The Current Ratio was at its lowest in in the September 2017 quarter at 2.18.

SymBio Pharmaceuticals Limited (SYMQY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of SymBio Pharmaceuticals Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SymBio Pharmaceuticals Limited (SYMQY) Average Current Ratio

How has SYMQY Current Ratio performed in the past?

The current Current Ratio of SymBio Pharmaceuticals Limited (SYMQY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

SymBio Pharmaceuticals Limited (SYMQY) Current Ratio vs. Peers

How is SYMQY’s Current Ratio compared to its peers?

SymBio Pharmaceuticals Limited’s Current Ratio is greater than Goodness Growth Holdings, Inc. (1.28), greater than Ecofibre Limited (0.64), less than Elegance Optical International Holdings Limited (0), greater than Biocartis Group N.V. (1.65), greater than Kiaro Holdings Corp. (1.23), greater than Herantis Pharma Oyj (8.10), greater than Karolinska Development AB (publ) (7.99), greater than Taihe Group, Inc. (0), greater than INNOCAN PHARMA Corp (3.70), greater than Oncopeptides AB (publ) (3.42),

Build a custom stock screener for SymBio Pharmaceuticals Limited (SYMQY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SymBio Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SymBio Pharmaceuticals Limited (SYMQY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SymBio Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.